These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36468313)

  • 1. Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?
    Loh WJ; Watts GF
    Curr Opin Endocrinol Diabetes Obes; 2023 Apr; 30(2):94-102. PubMed ID: 36468313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations.
    Ward NC; Watts GF; Bishop W; Colquhoun D; Hamilton-Craig C; Hare DL; Kangaharan N; Kostner KM; Kritharides L; O'Brien R; Mori TA; Nestel PJ; Nicholls SJ; Psaltis PJ; Raffoul N; White HD; Sullivan DR
    Heart Lung Circ; 2023 Mar; 32(3):287-296. PubMed ID: 36707360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives.
    Wu MF; Xu KZ; Guo YG; Yu J; Wu Y; Lin LM
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):739-748. PubMed ID: 31655942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
    Kronenberg F; Mora S; Stroes ESG; Ference BA; Arsenault BJ; Berglund L; Dweck MR; Koschinsky M; Lambert G; Mach F; McNeal CJ; Moriarty PM; Natarajan P; Nordestgaard BG; Parhofer KG; Virani SS; von Eckardstein A; Watts GF; Stock JK; Ray KK; Tokgözoğlu LS; Catapano AL
    Eur Heart J; 2022 Oct; 43(39):3925-3946. PubMed ID: 36036785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a).
    Chakraborty A; Pang J; Chan DC; Ellis KL; Hooper AJ; Bell DA; Burnett JR; Moses EK; Watts GF
    Atherosclerosis; 2022 May; 349():219-226. PubMed ID: 34862044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To test, or not to test: that is the question for the future of lipoprotein(a).
    Ellis KL; Chakraborty A; Moses EK; Watts GF
    Expert Rev Cardiovasc Ther; 2019 Apr; 17(4):241-250. PubMed ID: 30916582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All we need to know about lipoprotein(a).
    Bess C; Mehta A; Joshi PH
    Prog Cardiovasc Dis; 2024; 84():27-33. PubMed ID: 38759878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a): a Case for Universal Screening in Youth.
    Alankar A; Brar PC; Kohn B
    Curr Atheroscler Rep; 2023 Aug; 25(8):487-493. PubMed ID: 37405555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus and guidelines on lipoprotein(a) - seeing the forest through the trees.
    Kronenberg F; Mora S; Stroes ESG
    Curr Opin Lipidol; 2022 Dec; 33(6):342-352. PubMed ID: 36251423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care.
    Loh WJ; Chan DC; Mata P; Watts GF
    Front Genet; 2022; 13():905941. PubMed ID: 35571022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease.
    Verweij SL; de Ronde MWJ; Verbeek R; Boekholdt SM; Planken RN; Stroes ESG; Pinto-Sietsma SJ
    J Clin Lipidol; 2018; 12(3):597-603.e1. PubMed ID: 29550494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk.
    Mehta A; Vasquez N; Ayers CR; Patel J; Hooda A; Khera A; Blumenthal RS; Shapiro MD; Rodriguez CJ; Tsai MY; Sperling LS; Virani SS; Blaha MJ; Joshi PH
    J Am Coll Cardiol; 2022 Mar; 79(8):757-768. PubMed ID: 35210030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Lipoprotein(a) Clinically Actionable with Today's Evidence? The Answer is Yes.
    Ma GS; Chiou TT; Wilkinson MJ
    Curr Cardiol Rep; 2023 Oct; 25(10):1175-1187. PubMed ID: 37632608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses.
    Stürzebecher PE; Schorr JJ; Klebs SHG; Laufs U
    Atherosclerosis; 2023 Feb; 367():24-33. PubMed ID: 36764050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of lipoprotein(a) measurement in patients with or at risk of cardiovascular disease.
    Panza GA; Blazek O; Tortora J; Saucier S; Fernandez AB
    J Clin Lipidol; 2023; 17(6):748-755. PubMed ID: 37926592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities.
    Vuorio A; Watts GF; Schneider WJ; Tsimikas S; Kovanen PT
    J Intern Med; 2020 Jan; 287(1):2-18. PubMed ID: 31858669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States.
    Fonseca AF; Byrne H; Laguna A; Itani T; Studer R; Heo J; Dillon A; Ferber P; Costa-Scharplatz M
    J Manag Care Spec Pharm; 2023 May; 29(5):519-529. PubMed ID: 37121256
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoprotein(a) and mortality-a high risk relationship.
    Klingel R; Heibges A; Fassbender C
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):13-19. PubMed ID: 30838554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society.
    Kronenberg F; Mora S; Stroes ESG; Ference BA; Arsenault BJ; Berglund L; Dweck MR; Koschinsky ML; Lambert G; Mach F; McNeal CJ; Moriarty PM; Natarajan P; Nordestgaard BG; Parhofer KG; Virani SS; von Eckardstein A; Watts GF; Stock JK; Ray KK; Tokgözoğlu LS; Catapano AL
    Atherosclerosis; 2023 Jun; 374():107-120. PubMed ID: 37188555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.